COVEXIT Newsletter #14
Greetings, (click here for French) With a deadly disease such as COVID-19, and the havoc that characterized the pandemic response, especially in the first months,
Greetings, (click here for French) With a deadly disease such as COVID-19, and the havoc that characterized the pandemic response, especially in the first months,
In this video, Dr Peter McCullough, from the Baylor University Medical Center in Texas, explains how important early outpatient treatment is and presents guidelines for
In the past month, three open letters have been published by medical professionals in Belgium, and have received the support of thousands of medical doctors,
Dr Brian Tyson is one of the pioneers of early outpatient treatment for COVID-19, with zero death and just one short hospitalization out of some
by Jean-Pierre Kiekens, independent analyst, former university lecturer, graduate from the universities of Brussels and Oxford It was mainly the elderly who died from COVID-19
In the beginning of this fall season, everything points at an increasing number of outbreaks, infections, sick residents and deaths from COVID-19 in Canada’s elderly
In the second part of our interview with the esteemed Professor Thomas Borody from Australia, we discuss the question of ethical clinical trials, the progress
In this 4th and last part of our landmark interview with Professor Christian Perronne, we touch upon the following topics: The politicization of medicine Why
Today, Facebook took down the discussion group of COVEXIT, which had nearly 4,000 members. The usual explanation was given – a breach of community standards.
This is the first part of our interview with the esteemed Professor Thomas Borody, which covers the following aspects: What is the recommended ivermectin-based tri-therapy
In the third part of this interview, the esteemed Professor Christian Perronne, from France, shares his thoughts about immunization. Do we really need vaccines when
In this second part of our interview with Professor Christian Perronne, MD, PhD, from France, we cover the questions of clinical trials and therapy approval